Flagship VentureLabs IV, LLC's Net Worth
Estimate Recalculated Nov 5, 2024 07:09PM EST
Who is Flagship VentureLabs IV, LLC
Flagship VentureLabs IV, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., Seres Therapeutics, Inc., Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship VentureLabs IV, LLC's CIK is 0001642578
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
